Polymorphisms in cytokine and cellular adhesion molecule gene and susceptibility to hematotoxicity among workers exposed to benzene

Cancer Research

Volumn 65, Issue 20, 2005, Pages 9574-9581

  Lan, Qing ^a   Zhang, Luoping ^b   Shen, Min ^a   Smith, Martyn T ^b   Li, Guilan ^c   Vermeulen, Roel ^a   Rappaport, Stephen M ^d   Forrest, Matthew S ^b   Hayes, Richard B ^a   Linet, Martha ^a   Dosemeci, Mustafa ^a   Alter, Blanche P ^a   Weinberg, Rona S ^e   Yin, Songnian ^c   Yeager, Meredith ^a   Welch, Robert ^a   Waidyanatha, Suramya ^d   Kim, Sungkyoon ^d   Chanock, Stephen ^a   Rothman, Nathaniel ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d IL   (United States)

^e NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE; CD4 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD TOXICITY; CHINA; COLONY FORMATION; COLONY FORMING UNIT GEMM; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEMATOPOIESIS; HUMAN; LEUKEMOGENESIS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NATURAL KILLER CELL; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REGULATORY MECHANISM; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL;

ADULT; BENZENE; CELL ADHESION MOLECULES; CYTOKINES; FEMALE; HEMATOLOGIC DISEASES; HEMATOPOIESIS; HUMANS; MALE; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 27144553722     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-1419     Document Type: Article

References (55)

1. Hayes RB, Yin SN, Dosemeci M, et al. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine-National Cancer Institute Benzene Study Group. J Natl Cancer Inst 1997;89:1065-71.
2. Gist GL, Burg JR. Benzene-a review of the literature from a health effects perspective. Toxicol Ind Health 1997;13:661-714.
3. Lan Q, Zhang L, Li G, et al. Hematotoxicity in workers exposed to low levels of benzene. Science 2004;306:1774-6.
4. Ward E. Overview of preventable industrial causes of occupational cancer. Environ Health Perspect 1995;103 Suppl 8:197-203.
5. Chen H, Rupa DS, Tomar R, Eastmond DA. Chromosomal loss and breakage in mouse bone marrow and spleen cells exposed to benzene in vivo. Cancer Res 1994;54:3533-9.
6. Irons RD, Neptun DA. Effects of the principal hydroxymetabolites of benzene on microtubule polymerization. Arch Toxicol 1980;45:297-305.
7. Smith MT, Zhang L, Jeng M, et al. Hydroquinone, a benzene metabolite, increases the level of aneusomy of chromosomes 7 and 8 in human CD34-positive blood progenitor cells. Carcinogenesis 2000;21:1485-90.
8. Zhang L, Eastmond DA, Smith MT. The nature of chromosomal aberrations detected in humans exposed to benzene. Crit Rev Toxicol 2002;32:1-42.
9. Garnett HM, Cronkite EP, Drew RT. Effect of in vivo exposure to benzene on the characteristics of bone marrow adherent cells. Leuk Res 1983;7:803-10.
10. Thomas DJ, Sadler A, Subrahmanyam VV, et al. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells. Mol Pharmacol 1990;37:255-62.
11. Kalf GF, Renz JF, Niculescu R. p-Benzoquinone, a reactive metabolite of benzene, prevents the processing of pre-interleukins 1α and 1β to active cytokines by inhibition of the processing enzymes, calpain, and interleukin-1β converting enzyme. Environ Health Perspect 1996;104 Suppl 6:1251-6.
12. King AG, Landreth KS, Wierda D. Bone marrow stromal cell regulation of B-lymphopoiesis. II. Mechanisms of hydroquinone inhibition of pre-B cell maturation. J Pharmacol Exp Ther 1989;250:582-90.
13. Miller AC, Schattenberg DG, Malkinson AM, Ross D. Decreased content of the IL1α processing enzyme calpain in murine bone marrow-derived macrophages after treatment with the benzene metabolite hydroquinone. Toxicol Lett 1994;74:177-84.
14. Ross D, Siegel D, Schattenberg DG, Sun XM, Moran JL. Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: identification of target cells and a potential role for modulation of apoptosis in benzene toxicity. Environ Health Perspect 1996;104 Suppl 6:1177-82.
15. Goldstein BD. Benzene toxicity: a critical evaluation: introduction. J Toxicol Environ Health Suppl 1977;2:1-4.
16. Rothman N, Smith MT, Hayes RB, et al. Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C→T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res 1997;57:2839-42.
17. Hall BM, Gibson LF. Regulation of lymphoid and myeloid leukemic cell survival: role of stromal cell adhesion molecules. Leuk Lymphoma 2004;45:35-48.
18. Zhu J, Emerson SG. Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene 2002;21:3295-313.
19. Vermeulen R, Li G, Lan Q, et al. Detailed exposure assessment for a molecular epidemiology study of benzene in two shoe factories in China. Ann Occup Hyg 2004;48:105-16.
20. Packer BR, Yeager M, Staats B, et al. SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res 2004;32 (Database issue):D528-32.
21. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30.
22. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995;57:289-300.
23. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995;12:921-7.
24. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425-34.
25. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. 2004.
26. Stillman WS, Varella-Garcia M, Irons RD. The benzene metabolite, hydroquinone, selectively induces 5q31- and -7 in human CD34+. Exp Hematol 2000;28:169-76.
27. Kalf GF. Utility of a mouse model for studying the effects of benzene on the myeloid lineage: effects of hydroquinone on a model myeloid system. J Toxicol Environ Health A 2000;61:399-411.
28. Renz JF, Kalf GF. Role for interleukin-1 (IL-1) in benzene-induced hematotoxicity: inhibition of conversion of pre-IL-1α to mature cytokine in murine macrophages by hydroquinone and prevention of benzene-induced hematotoxicity in mice by IL-1α. Blood 1991;78:938-44.
29. King AG, Wierda D, Landreth KS. Bone marrow stromal cell regulation of B-lymphopoiesis. I. The role of macrophages, IL-1, and IL-4 in pre-B cell maturation. J Immunol 1988;141:2016-26.
30. Lee MH, Chung SW, Kang BY, Kim KM, Kim TS. Hydroquinone, a reactive metabolite of benzene, enhances interleukin-4 production in CD4+ T cells and increases immunoglobulin E levels in antigen-primed mice. Immunology 2002;106:496-502.
31. Forrest MS, Lan Q, Hubbard AE, et al. Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers. Environ Health Perspect 2005;113:801-7.
32. Snoeck HW, Lardon F, Van Bockstaele DR, Peetermans ME. Effects of interleukin-4 (IL4) on myelopoiesis: studies on highly purified CD34+ hematopoietic progenitor cells. Leukemia 1993;7:625-9.
33. Williams LM, Ricchetti G, Sarma U, Smallie T, Foxwell BM. Interleukin-10 suppression of myeloid cell activation-a continuing puzzle. Immunology 2004;113:281-92.
34. Jacobsen SE. IL12, a direct stimulator and indirect inhibitor of haematopoiesis. Res Immunol 1995;146:506-14.
35. Yssel H, Schneider P, Spits H. Production of IL4 by human T cells and regulation of differentiation of T-cell subsets by IL4. Res Immunol 1993;144:610-6.
36. Fuste B, Escolar G, Marin P, et al. G-CSF increases the expression of VCAM-1 on stromal cells promoting the adhesion of CD34+ hematopoietic cells: studies under flow conditions. Exp Hematol 2004;32:765-72.
37. Levesque JP, Takamatsu Y, Nilsson SK, Haylock DN, Simmons PJ. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 2001;98:1289-97.
38. Dominici R, Cattaneo M, Malferrari G, et al. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1α. Immunogenetics 2002;54:82-6.
39. Asensi V, Alvarez V, Valle E, et al. IL-1α (-889) promoter polymorphism is a risk factor for osteomyelitis. Am J Med Genet A 2003;119:132-6.
40. Rainero I, Bo M, Ferrero M, et al. Association between the interleukin-1α gene and Alzheimer's disease: a meta-analysis. Neurobiol Aging 2004;25:1293-8.
41. Choi EH, Lee HJ, Yoo T, Chanock SJ. A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis 2002;186:1207-11.
42. Choi EH, Foster CB, Taylor JG, et al. Association between chronic disseminated candidiasis in adult acute leukemia and common IL4 promoter haplotypes. J Infect Dis 2003;187:1153-6.
43. Hoebee B, Rietveld E, Bont L, et al. Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor α polymorphisms. J Infect Dis 2003;187:2-11.
44. Beghe B, Barton S, Rorke S, et al. Polymorphisms in the interleukin-4 and interleukin-4 receptor α chain genes confer susceptibility to asthma and atopy in a Caucasian population. Clin Exp Allergy 2003;33:1111-7.
45. Rockman MV, Hahn MW, Soranzo N, Goldstein DB, Wray GA. Positive selection on a human-specific transcription factor binding site regulating IL4 expression. Curr Biol 2003;13:2118-23.
46. Timmann C, Fuchs S, Thoma C, et al. Promoter haplotypes of the interleukin-10 gene influence proliferation of peripheral blood cells in response to helminth antigen. Genes Immun 2004;5:256-60.
47. Temple SE, Lim E, Cheong KY, et al. Alleles carried at positions -819 and -592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae. Immunogenetics 2003;55:629-32.
48. Eskdale J, Gallagher G, Verweij CL, et al. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A 1998;95:9465-70.
49. Chong WP, Ip WK, Wong WH, et al. Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immun 2004;5:484-92.
50. Lin MT, Storer B, Martin PJ, et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 2003;349:2201-10.
51. Lyon H, Lange C, Lake S, et al. IL10 gene polymorphisms are associated with asthma phenotypes in children. Genet Epidemiol 2004;26:155-65.
52. Scassellati C, Zanardini R, Squitti R, et al. Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease. Neurosci Lett 2004;356:119-22.
53. Hoppe C, Klitz W, Cheng S, et al. Gene interactions and stroke risk in children with sickle cell anemia. Blood 2004;103:2391-6.
54. Taylor JG, Tang DC, Savage SA, et al. Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood 2002;100:4303-9.
55. Kuersten S, Goodwin EB. The power of the 3′ UTR: translational control and development. Nat Rev Genet 2003;4:626-37.